| Ms Nana-amma Mintaa Owusu-donkor, LCSW | |
|
1326 S Governors Ave Ste A, Dover, DE 19904-4800 | |
| (302) 246-5527 | |
| Not Available |
| Full Name | Ms Nana-amma Mintaa Owusu-donkor |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 7 Years |
| Location | 1326 S Governors Ave Ste A, Dover, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952945867 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | Q1-0001739 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Exodus Behavioral Health Llc | 9931514247 | 4 |
News Archive
Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.
Addressing societal issues by enabling cross-disciplinary partnerships is an inherent part of a COST Actions' nature. But collaborations don't stop at the gate of these specific networks: multiple COST Actions have joined forces since the beginning of the pandemic to help advance research into COVID-19.
To better understand the organization of the brain and the perceptual tendencies in humans, a team of four scientists are recording video from four head-mounted cameras - with eyetracking and head movement - and assembling a massive video database with more than 240 hours of first-person video that can be used by researchers everywhere.
DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.
Like other data-driven organizations, healthcare networks are vulnerable to potentially crippling cyberattacks - but may lag behind other sectors in preparing for and avoiding data breaches, according to a series of articles and commentaries in the Fall issue of Frontiers of Health Services Management, an official publication of the American College of Healthcare Executives.
› Verified 1 days ago
| Entity Name | Exodus Behavioral Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013535442 PECOS PAC ID: 9931514247 Enrollment ID: O20210219000046 |
News Archive
Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.
Addressing societal issues by enabling cross-disciplinary partnerships is an inherent part of a COST Actions' nature. But collaborations don't stop at the gate of these specific networks: multiple COST Actions have joined forces since the beginning of the pandemic to help advance research into COVID-19.
To better understand the organization of the brain and the perceptual tendencies in humans, a team of four scientists are recording video from four head-mounted cameras - with eyetracking and head movement - and assembling a massive video database with more than 240 hours of first-person video that can be used by researchers everywhere.
DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.
Like other data-driven organizations, healthcare networks are vulnerable to potentially crippling cyberattacks - but may lag behind other sectors in preparing for and avoiding data breaches, according to a series of articles and commentaries in the Fall issue of Frontiers of Health Services Management, an official publication of the American College of Healthcare Executives.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Nana-amma Mintaa Owusu-donkor, LCSW 1326 S Governors Ave Ste A, Dover, DE 19904-4800 Ph: () - | Ms Nana-amma Mintaa Owusu-donkor, LCSW 1326 S Governors Ave Ste A, Dover, DE 19904-4800 Ph: (302) 246-5527 |
News Archive
Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.
Addressing societal issues by enabling cross-disciplinary partnerships is an inherent part of a COST Actions' nature. But collaborations don't stop at the gate of these specific networks: multiple COST Actions have joined forces since the beginning of the pandemic to help advance research into COVID-19.
To better understand the organization of the brain and the perceptual tendencies in humans, a team of four scientists are recording video from four head-mounted cameras - with eyetracking and head movement - and assembling a massive video database with more than 240 hours of first-person video that can be used by researchers everywhere.
DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.
Like other data-driven organizations, healthcare networks are vulnerable to potentially crippling cyberattacks - but may lag behind other sectors in preparing for and avoiding data breaches, according to a series of articles and commentaries in the Fall issue of Frontiers of Health Services Management, an official publication of the American College of Healthcare Executives.
› Verified 1 days ago
Mrs. Leah Denise Sullivan, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1151 Walker Rd, Dover, DE 19904 Phone: 302-674-2380 | |
Tamika L Culver, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9 E Loockerman St, Suite 308, Dover, DE 19901 Phone: 302-244-8054 | |
Brittany Cosme, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 318 Crickle Creek Ln, Dover, DE 19904 Phone: 302-359-4517 | |
Mrs. Crystal Lynn Conley, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2099 S Dupont Hwy, Dover, DE 19901 Phone: 302-674-1600 Fax: 302-531-0850 | |
Ashley Mcgee, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1103 Westview Ter, Dover, DE 19904 Phone: 302-531-8882 | |
E Faye Bibee Friedman, M.S.W., L.C.S.W. Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 121 W Loockerman St, Dover, DE 19904 Phone: 302-674-1367 Fax: 302-674-1602 | |
Karen Am Favors, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9 E Loockerman St Ste 213, Dover, DE 19901 Phone: 302-677-1758 Fax: 302-677-1759 |